Key facts
- Innovaccer’s last known valuation is $3.5B (Jan 2025).
- It has raised $653.6M across 5 recorded rounds; the latest was Seed Round ($2.1M) in Aug 2025.
- Notable investors include 500 Global, Lightspeed Venture Partners, Tiger Global Management, Peak XV Partners, B Capital Group — 48 tracked in total.
- Innovaccer has filed 4 Form Ds with the SEC since 2016, most recently Feb 2021 ($74.8M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 48 names
- ·Watchlist + deal alerts for Innovaccer
Funding rounds
5 roundsAbout Innovaccer
Developer of a healthcare data technology platform intended to deliver intelligent and connected experiences that advance health outcomes. The company's platform aggregates, analyses, and activates patient data from diverse sources such as electronic health records (EHRs), medical devices, and other systems, facilitates communication and collaboration among teams and offers tools for managing billing, claims processing, and reimbursement to optimize financial operations and reduce administrative burdens, enabling healthcare organizations to streamline clinical workflows, enhance care coordination, and improve patient outcomes.
- Sector
- Health Care
- HQ
- San Francisco, CA, United States
- Founded
- 2014
- Employees
- 1,786
- Website
- innovaccer.com/
- Ownership
- Privately Held (backing)
Innovaccer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innovaccer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innovaccer in its N-PORT filings yet. We sweep new filings monthly.